European regulator is urged to release data on drugs approved in past 10 yearsBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5905 (Published 30 September 2013) Cite this as: BMJ 2013;347:f5905
- Zosia Kmietowicz
The European drug regulator should be more radical in demanding full disclosure of clinical trial data from drug companies, four groups representing the interest of patients have said.
The European Medicines Agency (EMA) should make available all data on the drugs it has approved in the last 10 years and not just from March 2014 as the agency has proposed, the campaigners say.
Since June this year the agency has been consulting on who should have access to what data when it begins publishing in January 2014 …
Log in using your username and password
Log in through your institution
Sign up for a free trial